Pharma Journalist - Page 32 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Genentech Licenses SanegeneBio RNAi Therapy in $1.5B Deal

FDA Grants Breakthrough Status to Immix AL Amyloidosis Therapy

WuXi Biologics, Sinorda Partner on Bispecific Antibody for IBD

Recordati, Moderna Partner on mRNA Therapy for Rare Metabolic Disease

IQVIA, Boehringer Ingelheim Partner on Global Commercial Data Transformation

FDA Grants Breakthrough Status to Biogen’s Lupus Skin Therapy

Sensorion Raises €60m to Advance Gene Therapies for Hearing Loss

AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies

AstraZeneca Pledges $15bn to Expand China R&D, Manufacturing

Repertoire, Lilly Team Up on Tolerizing Autoimmune Therapies